Will Mercks Gardasil HPV Vaccine be its Next Vioxx?
By Richard Gale (about the author) Page 3 of 4 page(s) self.name = ‘mainwindow’; opednews.com In her lecture to the 2010 Vaccine Conference sponsored by the National Vaccine Information Center, Dr. Harper lectured that the safety issues with Gardasil are so serious that the rate of serious adverse events is greater in the US than the incidence rate of cervical cancer. The incidence of cervical cancer is so low, there is almost no supporting evidence to conclude massive vaccination would lower the rate. In her analysis of Harper’s findings, Bevington states, “in the US to even touch cervical cancer rates in this country, you would have to vaccinate every single 11 year old in the US every year for 70 years to even drop [the cervical cancer rate] by one percent.” Merck’s Legislative Zombies In 2007, almost every state had legislation filed to mandate the HPV vaccine. It is rather extraordinary that so many states would have state officials in unison calling for mandatory vaccination. Wel
